ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) today announced that the U.S. Food and Drug Administration (FDA) has approved its premarket approval application ...
* Cardiovascular Systems Inc - initiated a voluntary recall of its 7-10014 saline infusion pump * Cardiovascular Systems says csi expects to record approximately $1.5 million of expenses in its Q3 of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results